Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration on Monday approved an injectable drug that can protect children up to 2 years old from ...
The US Food and Drug Administration (FDA) on Monday approved a new drug against respiratory syncytial virus (RSV) for newborns and infants. The monoclonal antibody Beyfortus (nirsevimab-alip), which ...
The Food and Drug Administration on Monday approved an injectable drug that can protect children up to 2 years old from respiratory syncytial virus. Subscribe to read this story ad-free Get unlimited ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results